PHASE-II STUDY OF RECOMBINANT ALPHA-2 INTERFERON IN RESISTANT MULTIPLE-MYELOMA

被引：99
作者：
COSTANZI, JJ
COOPER, MR
SCARFFE, JH
OZER, H
GRUBBS, SS
FERRARESI, RW
POLLARD, RB
SPIEGEL, RJ
机构：
[1] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, WINSTON SALEM, NC 27103 USA
[2] UNIV MANCHESTER, MANCHESTER M13 9PL, LANCS, ENGLAND
[3] NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, CTR CANC, BUFFALO, NY 14263 USA
[4] DARTMOUTH COLL, HITCHCOCK MED CTR, HANOVER, NH 03756 USA
[5] SCHERING CORP, KENILWORTH, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1985年 / 3卷 / 05期
关键词：
D O I：
10.1200/JCO.1985.3.5.654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：654 / 659
页数：6
相关论文
共 25 条
  • [1] AAPRO MS, 1983, CANCER CHEMOTH PHARM, V10, P161
  • [2] ALEXANIAN R, 1982, CLIN HAEMATOL, V11, P211
  • [3] ANALYSIS OF SURVIVAL BY TUMOR RESPONSE
    ANDERSON, JR
    CAIN, KC
    GELBER, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) : 710 - 719
  • [4] BENNETT JM, 1978, CANCER TREAT REP, V62, P1367
  • [5] PROGRESS IN THE TREATMENT OF PLASMA-CELL MYELOMA
    BERGSAGEL, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (08) : 510 - 512
  • [6] BERGSAGEL DE, 1972, CAN MED ASSOC J, V107, P851
  • [7] BERGSAGEL DE, 1962, CANCER CHEMOTH REP, P87
  • [8] BLADE J, 1983, CANCER, V52, P786, DOI 10.1002/1097-0142(19830901)52:5<786::AID-CNCR2820520505>3.0.CO
  • [9] 2-H
  • [10] COHEN JH, 1972, AM J CLIN ONCOL-CANC, V5, P21
123